Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Gori

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Expert Review of Cardiovascular Therapy|December 8, 2015
Sacubitril/valsartan (LCZ696) for the treatment of heart failureMauro Gori, Michele Senni
Cardiac Failure Review|August 9, 2017
Haemodynamics of Heart Failure With Preserved Ejection Fraction: A Clinical PerspectiveMauro Gori, Attilio Iacovoni, Michele Senni
International Journal of Cardiology|November 14, 2018
Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectivesMauro Gori, Emilia D'Elia, Michele Senni
Cardiac Failure Review|July 22, 2022
Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful TherapyMauro Gori, Emilia D'Elia, Edoardo Sciatti, et al.
Giornale Italiano Di Cardiologia (2006)|February 14, 2020
[Heart failure with preserved ejection fraction: an update on diagnosis and treatment]Mauro Gori, Emilia D'Elia, Giulia Zambelli, et al.
International Journal of Cardiology|July 6, 2016
Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugsMauro Gori, Maurizio Volterrani, Massimo Piepoli, et al.
European Heart Journal. Case Reports|December 28, 2023
Potential proarrhythmic side effect of high dose and prolonged infusion of sodium nitroprusside through calcium ion reduction: a case reportLuca Fazzini, Mauro Gori, Christian Cadeddu Dessalvi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 26, 2020
Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fractionMauro Gori, Emilia D'Elia, Anita Iorio, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 27, 2005
Tako-Tsubo cardiomyopathy: new insights into the possible underlying pathophysiologyElisa Merli, Stephen Sutcliffe, Mauro Gori, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossibleEdoardo Sciatti, Mauro Gori, Emilia D'elia, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Expert Review of Cardiovascular Therapy|December 8, 2015
Sacubitril/valsartan (LCZ696) for the treatment of heart failureMauro Gori, Michele Senni
Cardiac Failure Review|August 9, 2017
Haemodynamics of Heart Failure With Preserved Ejection Fraction: A Clinical PerspectiveMauro Gori, Attilio Iacovoni, Michele Senni
International Journal of Cardiology|November 14, 2018
Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectivesMauro Gori, Emilia D'Elia, Michele Senni
Cardiac Failure Review|July 22, 2022
Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful TherapyMauro Gori, Emilia D'Elia, Edoardo Sciatti, et al.
Giornale Italiano Di Cardiologia (2006)|February 14, 2020
[Heart failure with preserved ejection fraction: an update on diagnosis and treatment]Mauro Gori, Emilia D'Elia, Giulia Zambelli, et al.
International Journal of Cardiology|July 6, 2016
Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugsMauro Gori, Maurizio Volterrani, Massimo Piepoli, et al.
European Heart Journal. Case Reports|December 28, 2023
Potential proarrhythmic side effect of high dose and prolonged infusion of sodium nitroprusside through calcium ion reduction: a case reportLuca Fazzini, Mauro Gori, Christian Cadeddu Dessalvi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 26, 2020
Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fractionMauro Gori, Emilia D'Elia, Anita Iorio, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 27, 2005
Tako-Tsubo cardiomyopathy: new insights into the possible underlying pathophysiologyElisa Merli, Stephen Sutcliffe, Mauro Gori, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossibleEdoardo Sciatti, Mauro Gori, Emilia D'elia, et al.
Pageof 11